CIK 0001785279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Metagenomi Therapeutics, Inc.
Sign in to watch- Ticker
- MGX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 813909017
- Phone
- (510) 871-4880
- Business address
- 5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
- Former names
- Metagenomi, Inc., Metagenomi Technologies, LLC
- Open-market buys, last 90 days
- $23,401
- in 1 filing
- Open-market sales, last 90 days
- $5,107
- in 3 filings
Net +$18,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-09 | Reid Laurence Director | Purchase | +19,883 | $1.17 | $23K | 19,883 |
| 2026-09-09 | Reid Laurence Director | Purchase | +117 | $1.18 | $138 | 20,000 |
| 2026-09-08 | Wein Matthew See Remarks | Sale | −358 | $1.16 | $415 | 126,133 |
| 2026-09-08 | Irish Jian See Remarks | Sale | −2,140 | $1.16 | $2K | 375,393 |
| 2026-09-08 | Wapnick Pamela Chief Financial Officer | Sale | −1,911 | $1.16 | $2K | 206,580 |
| 2026-06-09 | Reid Laurence Director | Grant or award · Stock Option (Right to Buy) | +17,400 | 17,400 | ||
| 2026-06-09 | Dere Willard H Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2026-06-09 | BJERKHOLT ERIC Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2026-06-09 | Eckhardt Juergen Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2026-06-05 | Wapnick Pamela Chief Financial Officer | Sale | −2,884 | $1.30 | $4K | 208,491 |
| 2026-06-05 | Irish Jian See Remarks | Sale | −3,737 | $1.30 | $5K | 377,533 |
| 2026-06-05 | Wein Matthew See Remarks | Sale | −558 | $1.30 | $725 | 126,491 |
| 2026-04-01 | Irish Jian See Remarks | Grant or award | +46,000 | 379,770 | ||
| 2026-04-01 | Irish Jian See Remarks | Grant or award · Stock Option (Right to Buy) | +276,000 | 276,000 | ||
| 2026-04-01 | Wein Matthew See Remarks | Grant or award | +11,000 | 125,549 | ||
| 2026-04-01 | Wein Matthew See Remarks | Grant or award · Stock Option (Right to Buy) | +68,000 | 68,000 | ||
| 2026-04-01 | Wapnick Pamela Chief Financial Officer | Grant or award | +24,000 | 211,375 | ||
| 2026-04-01 | Wapnick Pamela Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +144,000 | 144,000 | ||
| 2026-03-05 | Wapnick Pamela Chief Financial Officer | Sale | −1,581 | $1.60 | $3K | 187,375 |
| 2026-03-05 | Wein Matthew See Remarks | Sale | −482 | $1.60 | $771 | 114,549 |
Page 1 of 6 · 101 trades